Skip to main content
. 2014 Oct 2;143(3):396–405. doi: 10.1111/imm.12322

Table 1.

Disease incidence of different treatment groups after immunization

Days afer immunization

30 32 34 36 38 40 42 44 46 48 50
CFA 0/20 0/20 0/20** 0/20** 0/20*** 0/20*** 0/20*** 0/20*** 0/20*** 0/20*** 0/20***
EAMG 1/20 3/20 7/20 7/20 12/20 13/20 17/20 19/20 19/20 19/20 19/20
Anti-IL-9 Abs, Low dose 0/19 4/19 4/19 7/19 10/19 11/19 14/19 15/19 16/19 16/19 16/19
Anti-IL-9 Abs, High dose 0/19 1/19 2/19 3/19 4/19* 5/19* 7/19** 7/19*** 8/19*** 8/19*** 10/19**

Abbreviations: CFA, complete Freund's adjuvant; EAMG, experimental autoimmune myasthenia gravis; IL-9 Abs, interleukin-9 antibodies.

Incidences were compared with the experimental autoimmune myasthenia gravis (EAMG) group.

Statistical comparisons among the clinical incidences were made by Fisher's exact test.

*

P < 0.05,

**

P < 0.01,

***

P < 0.001.